Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
The Journal of Thoracic and Cardiovascular Surgery|March 10, 2017
Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503Leslie J Kohman, Lin Gu, Nasser Altorki, et al.The Journal of Thoracic and Cardiovascular Surgery|April 14, 2020
Treatment of cT3N1M0/IIIA non-small cell lung cancer and the risk of underuse of surgeryMohamed Rahouma, Mohamed Kamel, Abu Nasar, et al.World Journal of Surgery|April 12, 2023
Surgical Treatment at an Academic Medical Center is Associated with Statistically Insignificant Lung Cancer Survival Outcome Differences Related to ZIP CodeJack Wish, Jonathan Villena-Vargas, Sebron Harrison, et al.Journal of Thoracic Disease|November 18, 2024
A robotic-assisted thymectomy is equivalent to a transsternal resection in large thymomasShaikha Al-Thani, Mohamed Rahouma, Jonathan Villena-Vargas, et al.The Annals of Thoracic Surgery|November 15, 2024
Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer ≤2 cm?Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, et al.Journal of Pathology Informatics|November 19, 2013
Full-field optical coherence tomography for the analysis of fresh unstained human lobectomy specimensManu Jain, Navneet Narula, Bekheit Salamoon, et al.Annals of Surgery|July 22, 2022
Ten-Year Survival and Recurrence Patterns After Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the EsophagusNasser Altorki, Nathan Mynard, Abu Nasar, et al.The Journal of Thoracic and Cardiovascular Surgery|November 5, 2023
Should sampling of three N2 stations be a quality metric for curative resection of stage I lung cancer?Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, et al.The Journal of Thoracic and Cardiovascular Surgery|January 27, 2018
Are minimum volume standards appropriate for lung and esophageal surgery?Sebron Harrison, Virginia Tangel, Xian Wu, et al.The Journal of Thoracic and Cardiovascular Surgery|August 26, 2022
Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: Results from a randomized trialBenjamin Lee, Nathan Mynard, Abu Nasar, et al.Pageof 9